{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:50:50Z","timestamp":1791114650778,"version":"4.1.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T00:00:00Z","timestamp":1356912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053492","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T22:14:11Z","timestamp":1356992051000},"page":"e53492","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem\/Progenitor Cells in Humanized BLT Mice"],"prefix":"10.1371","volume":"7","author":[{"given":"Gene-Errol E.","family":"Ringpis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Arokium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Camba-Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cortado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sahakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetoshi","family":"Narukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi N.","family":"Kandarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff P.","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Sung","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irvin S. Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,31]]},"reference":[{"key":"ref1","unstructured":"UNAIDS (2011) 2011 World AIDS Day Report."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"DD Richman","year":"2009","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/335395a0","article-title":"Gene therapy. Intracellular immunization","volume":"335","author":"D Baltimore","year":"1988","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nbt1367","article-title":"Genetic therapies against HIV","volume":"25","author":"JJ Rossi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1093\/hmg\/ddr160","article-title":"Ex vivo gene therapy for HIV-1 treatment","volume":"20","author":"LJ Scherer","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.biochem.74.050304.091637","article-title":"Gene therapy: twenty-first century medicine","volume":"74","author":"IM Verma","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2011.12.015","article-title":"Hematopoietic-stem-cell-based gene therapy for HIV disease","volume":"10","author":"HP Kiem","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-4614-0980-9_10","article-title":"Molecular mechanisms of HIV entry","volume":"726","author":"CB Wilen","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.276.5309.51","article-title":"Coreceptors: implications for HIV pathogenesis and therapy","volume":"276","author":"JP Moore","year":"1997","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2000.17719.x","article-title":"Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands","volume":"177","author":"G Simmons","year":"2000","journal-title":"Immunol Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1002020","DOI":"10.1371\/journal.ppat.1002020","article-title":"Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases","volume":"7","author":"CB Wilen","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-6405-5-16","article-title":"Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance","volume":"5","author":"M Tamhane","year":"2008","journal-title":"AIDS Research and Therapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-135-9-200111060-00008","article-title":"Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3\u2032A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data","volume":"135","author":"JP Ioannidis","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng1369","article-title":"Human genes that limit AIDS","volume":"36","author":"SJ O'Brien","year":"2004","journal-title":"Nat Genet"},{"key":"ref15","first-page":"959","article-title":"Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study","volume":"277","author":"MW Smith","year":"1997","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"K Allers","year":"2011","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"G Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"A Fire","year":"1998","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1128\/JVI.77.22.11964-11972.2003","article-title":"Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector","volume":"77","author":"MT Lee","year":"2003","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mt.6300382","article-title":"Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition","volume":"16","author":"O ter Brake","year":"2008","journal-title":"Mol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates","volume":"104","author":"DS An","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"XF Qin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","article-title":"Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors","volume":"14","author":"DS An","year":"2006","journal-title":"Mol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/sj.mt.6300157","article-title":"Safety and efficacy of a lentiviral vector containing three anti-HIV genes\u2013CCR5 ribozyme, tat-rev siRNA, and TAR decoy\u2013in SCID-hu mouse-derived T cells","volume":"15","author":"J Anderson","year":"2007","journal-title":"Mol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/gt.2011.149","article-title":"Current progress in the development of RNAi-based therapeutics for HIV-1","volume":"18","author":"J Zhou","year":"2011","journal-title":"Gene Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DL DiGiusto","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-7-8","article-title":"Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5","volume":"7","author":"S Shimizu","year":"2009","journal-title":"Genet Vaccines Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jgm.1440","article-title":"Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction","volume":"12","author":"M Liang","year":"2010","journal-title":"J Gene Med"},{"key":"ref29","first-page":"66ra66","article-title":"An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice","volume":"3","author":"CP Neff","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/mt.2011.207","article-title":"Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice","volume":"19","author":"J Zhou","year":"2011","journal-title":"Mol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/mt.2009.271","article-title":"RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice","volume":"18","author":"SS Kim","year":"2010","journal-title":"Mol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","article-title":"T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice","volume":"134","author":"P Kumar","year":"2008","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e20209","DOI":"10.1371\/journal.pone.0020209","article-title":"A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice","volume":"6","author":"CP Neff","year":"2011","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e15257","DOI":"10.1371\/journal.pone.0015257","article-title":"Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model","volume":"5","author":"CP Neff","year":"2010","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"N Holt","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model","volume":"115","author":"S Shimizu","year":"2010","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"MW Melkus","year":"2006","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","article-title":"Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation","volume":"108","author":"P Lan","year":"2006","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/00002030-200008180-00011","article-title":"Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue","volume":"14","author":"PA Anton","year":"2000","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-4690-6-55","article-title":"96 shRNAs designed for maximal coverage of HIV-1 variants","volume":"6","author":"GJ McIntyre","year":"2009","journal-title":"Retrovirology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"J He","year":"1995","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"RI Connor","year":"1995","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1128\/JVI.67.11.6365-6378.1993","article-title":"Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity","volume":"67","author":"DF Purcell","year":"1993","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(79)90357-X","article-title":"A detailed model of reverse transcription and tests of crucial aspects","volume":"18","author":"E Gilboa","year":"1979","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/BC.2004.103","article-title":"RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter","volume":"385","author":"D Koper-Emde","year":"2004","journal-title":"Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1128\/JVI.73.11.8966-8974.1999","article-title":"A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor","volume":"73","author":"A Trkola","year":"1999","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e1000342","DOI":"10.1371\/journal.ppat.1000342","article-title":"Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells","volume":"5","author":"M Kamata","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jgm.1078","article-title":"Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions","volume":"9","author":"O ter Brake","year":"2007","journal-title":"J Gene Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"A Adachi","year":"1986","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1128\/JVI.79.16.10210-10217.2005","article-title":"Formaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses","volume":"79","author":"B Poon","year":"2005","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/08892220050058344","article-title":"Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1","volume":"16","author":"M Baba","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.3646751","article-title":"Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms","volume":"236","author":"Y Koyanagi","year":"1987","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2199-5-9","article-title":"Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors","volume":"5","author":"RJ Fish","year":"2004","journal-title":"BMC Mol Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1173","article-title":"Induction of an interferon response by RNAi vectors in mammalian cells","volume":"34","author":"AJ Bridge","year":"2003","journal-title":"Nat Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1634\/stemcells.2008-0583","article-title":"Busulfan produces efficient human cell engraftment in NOD\/LtSz-Scid IL2Rgamma(null) mice","volume":"27","author":"J Hayakawa","year":"2009","journal-title":"Stem Cells"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/348069a0","article-title":"HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain","volume":"348","author":"WA O'Brien","year":"1990","journal-title":"Nature"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ymthe.2005.07.524","article-title":"Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy","volume":"12","author":"MJ Li","year":"2005","journal-title":"Mol Ther"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/mt.2009.187","article-title":"Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy","volume":"17","author":"JS Anderson","year":"2009","journal-title":"Mol Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/nar\/27.2.446","article-title":"The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure","volume":"27","author":"BI Klasens","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1093\/nar\/gkm437","article-title":"A systematic analysis of the effect of target RNA structure on RNA interference","volume":"35","author":"EM Westerhout","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/nar\/gki220","article-title":"HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome","volume":"33","author":"EM Westerhout","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","article-title":"Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition","volume":"78","author":"AT Das","year":"2004","journal-title":"J Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12026-010-8169-7","article-title":"The use of cell-delivered gene therapy for the treatment of HIV\/AIDS","volume":"48","author":"GP Symonds","year":"2010","journal-title":"Immunol Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JVI.73.3.2343-2349.1999","article-title":"Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage","volume":"73","author":"A Morner","year":"1999","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T15:51:59Z","timestamp":1595173919000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053492"}},"subtitle":[],"editor":[{"given":"Roberto F.","family":"Speck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,31]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053492","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,31]]}}}